Difference in trajectories according to early amyloid accumulation in cognitively unimpaired elderly

被引:1
作者
Kim, Young Ju [1 ,2 ]
Yun, Jihwan [1 ,3 ]
Seo, Sang Won [1 ,2 ,4 ,5 ]
Kim, Jun Pyo [1 ,2 ]
Jang, Hyemin [1 ,6 ]
Kim, Hee Jin [1 ,2 ,4 ,5 ]
Na, Duk L. [1 ,2 ]
Woo, Sookyoung [7 ]
Chun, Min Young [1 ,8 ,9 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea
[2] Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea
[3] Soonchunhyang Univ, Bucheon Hosp, Sch Med, Dept Neurol, Bucheon, South Korea
[4] Sungkyunkwan Univ, Dept Digital Hlth, SAIHST, Seoul, South Korea
[5] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea
[6] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Neurol, Seoul, South Korea
[7] Samsung Biomed Res Inst, Biostat Team, Seoul, South Korea
[8] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea
[9] Yonsei Univ Hlth Syst, Yongin Severance Hosp, Dept Neurol, Yongin, South Korea
关键词
Alzheimer's disease; amyloid; cognition; latent class growth analysis; longitudinal study; positron emission tomography; trajectory; PRECLINICAL ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; DECLINE; ASSOCIATION; DEPOSITION; EPSILON-4; FRAMEWORK; PATHOLOGY;
D O I
10.1111/ene.16482
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: Amyloid (3 (A(3), a major biomarker of Alzheimer's disease, leads to tau accumulation, neurodegeneration and cognitive decline. Modelling the trajectory of A(3 accumulation in cognitively unimpaired (CU) individuals is crucial, as treatments targeting A(3 are anticipated. The evolution of A(3 levels was investigated to determine whether it could lead to classification into different groups by studying longitudinal A(3 changes in older CU individuals, and differences between the groups were compared. Methods: A total of 297 CU participants were included from the Alzheimer's Disease Neuroimaging Initiative database, and these participants underwent apolipoprotein E (APOE) genotyping, neuropsychological testing, brain magnetic resonance imaging, and an average of 3.03 follow-up 18 F-florbetapir positron emission tomography scans. Distinct A(3 trajectory patterns were classified using latent class growth analysis, and longitudinal cognitive performances across these patterns were assessed with a linear mixed effects model. Results: The optimal model consisted of three classes, with a high entropy value of 0.947. The classes were designated as follows: class 1, non-accumulation group (n n = 197); class 2, late accumulation group (n n = 70); and class 3, early accumulation group (n n = 30). The late accumulation and early accumulation groups had more APOE epsilon 4 carriers than the non- accumulation group. The longitudinal analysis of cognitive performance revealed that the early accumulation group showed the steepest decline (modified Preclinical Alzheimer's Cognitive Composite with digit symbol substitution [mPACCdigit], p < 0.001; modified Preclinical Alzheimer's Cognitive Composite with trails B [mPACCtrailsB], p < 0.001) and the late accumulation group showed a steeper decline (mPACCdigit, p = 0.014; mPACCtrailsB, p = 0.007) compared to the non-accumulation group. Conclusions: Our study showed the heterogeneity of A[3 accumulation trajectories in CU older individuals. The prognoses for cognitive decline differ according to the A[3 trajectory patterns.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Cerebral Amyloid Deposition and Dual-Tasking in Cognitively Normal, Mobility Unimpaired Older Adults
    Nadkami, Neelesh K.
    Lopez, Oscar L.
    Perera, Subashan
    Studenski, Stephanie A.
    Snitz, Beth E.
    Erickson, Kirk I.
    Mathis, Chester A.
    Nebes, Robert D.
    Redfern, Mark
    Klunk, William E.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2017, 72 (03): : 431 - 437
  • [22] Amyloid-β positivity is less prevalent in cognitively unimpaired KLOTHO KL-VS heterozygotes
    Cook, Noah
    Driscoll, Ira
    Gaitan, Julian M.
    Glittenberg, Matthew
    Betthauser, Tobey J.
    Carlsson, Cynthia M.
    Johnson, Sterling C.
    Asthana, Sanjay
    Zetterberg, Henrik
    Blennow, Kaj
    Kollmorgen, Gwendlyn
    Quijano-Rubio, Clara
    Dubal, Dena B.
    Okonkwo, Ozioma C.
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 102 (02) : 480 - 490
  • [23] APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly
    Anniina Snellman
    Laura L. Ekblad
    Jouni Tuisku
    Mikko Koivumäki
    Nicholas J. Ashton
    Juan Lantero-Rodriguez
    Thomas K. Karikari
    Semi Helin
    Marco Bucci
    Eliisa Löyttyniemi
    Riitta Parkkola
    Mira Karrasch
    Michael Schöll
    Henrik Zetterberg
    Kaj Blennow
    Juha O. Rinne
    Alzheimer's Research & Therapy, 15
  • [24] The amyloid beta 42/38 ratio as a plasma biomarker of early memory deficits in cognitively unimpaired older adults
    Bamford, Alison R.
    Adams, Jenna N.
    Kim, Soyun
    McMillan, Liv C.
    Malhas, Rond
    Mapstone, Mark
    Hitt, Brian D.
    Yassa, Michael A.
    Thomas, Elizabeth A.
    NEUROBIOLOGY OF AGING, 2024, 144 : 12 - 18
  • [25] Indicators of amyloid burden in a population-based study of cognitively normal elderly
    Mielke, Michelle M.
    Wiste, Heather J.
    Weigand, Stephen D.
    Knopman, David S.
    Lowe, Val J.
    Roberts, Rosebud O.
    Geda, Yonas E.
    Swenson-Dravis, Dana M.
    Boeve, Bradley F.
    Senjem, Matthew L.
    Vemuri, Prashanthi
    Petersen, Ronald C.
    Jack, Clifford R., Jr.
    NEUROLOGY, 2012, 79 (15) : 1570 - 1577
  • [26] The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly
    Wirth, Miranka
    Oh, Hwamee
    Mormino, Elizabeth C.
    Markley, Candace
    Landau, Susan M.
    Jagust, William J.
    ALZHEIMERS & DEMENTIA, 2013, 9 (06) : 687 - 698
  • [27] Respective influence of beta-amyloid and APOE ε4 genotype on medial temporal lobe subregions in cognitively unimpaired older adults
    de Flores, Robin
    Kuhn, Elizabeth
    Landeau, Brigitte
    Delcroix, Nicolas
    Gonneaud, Julie
    Vivien, Denis
    Demeilliez-Servouin, Solene
    Chauveau, Lea
    Chetelat, Gael
    NEUROBIOLOGY OF DISEASE, 2023, 181
  • [28] Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly
    Koivumaki, Mikko
    Ekblad, Laura
    Lantero-Rodriguez, Juan
    Ashton, Nicholas J.
    Karikari, Thomas K.
    Helin, Semi
    Parkkola, Riitta
    Lotjonen, Jyrki
    Zetterberg, Henrik
    Blennow, Kaj
    Rinne, Juha O.
    Snellman, Anniina
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [29] Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease
    Chatterjee, Pratishtha
    Elmi, Mitra
    Goozee, Kathryn
    Shah, Tejal
    Sohrabi, Hamid R.
    Dias, Cintia B.
    Pedrini, Steve
    Shen, Kaikai
    Asih, Prita R.
    Dave, Preeti
    Taddei, Kevin
    Vanderstichele, Hugo
    Zetterberg, Henrik
    Blennow, Kaj
    Martins, Ralph N.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (03) : 775 - 783
  • [30] Interaction of amyloid and tau on cortical microstructure in cognitively unimpaired adults
    Vogt, Nicholas M.
    Hunt, Jack F., V
    Adluru, Nagesh
    Ma, Yue
    Van Hulle, Carol A.
    Dean, Douglas C., III
    Kecskemeti, Steven R.
    Chin, Nathaniel A.
    Carlsson, Cynthia M.
    Asthana, Sanjay
    Johnson, Sterling C.
    Kollmorgen, Gwendlyn
    Batrla, Richard
    Wild, Norbert
    Buck, Katharina
    Zetterberg, Henrik
    Alexander, Andrew L.
    Blennow, Kaj
    Bendlin, Barbara B.
    ALZHEIMERS & DEMENTIA, 2022, 18 (01) : 65 - 76